This inventor holds 3 USPTO granted patents. Top assignee: Aegera Therapeutics, Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Kimberley E Hewitt: Innovator in Neuroprotective Agents
Introduction
Kimberley E Hewitt is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of neuroprotective agents, with a focus on treating neuronal disorders of the central and peripheral nervous systems. With a total of 3 patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
One of her latest patents involves compounds of Formula I, specifically Imidazo[2, 1-b]-1,3,4-thiadiazole sulfonamides. This invention relates to the use of these compounds as neuroprotective agents, showcasing their potential in treating various neuronal disorders. The innovative approach taken by Kimberley highlights her commitment to improving health outcomes through scientific research.
Career Highlights
Kimberley is currently associated with Aegera Therapeutics, Inc., where she continues to develop her groundbreaking ideas. Her work at Aegera Therapeutics emphasizes her dedication to advancing therapeutic solutions in the medical field.
Collaborations
Throughout her career, Kimberley has collaborated with notable colleagues, including James B Jaquith and Alain Boudreault. These partnerships have further enriched her research and contributed to the success of her inventions.
Conclusion
Kimberley E Hewitt stands out as an influential inventor in the realm of neuroprotective agents. Her innovative work and collaborations are making a significant impact in the treatment of neuronal disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile